Literature DB >> 3435490

Cyclosporin A augments angiotensin II-stimulated rise in intracellular free calcium in vascular smooth muscle cells.

J Pfeilschifter1, U T Rüegg.   

Abstract

Pretreatment of rat vascular smooth muscle cells with the immunosuppressive drug cyclosporin A caused concentration- and time-dependent increases in both the amplitude and duration of the angiotensin II-induced rise in cytosolic free calcium, as measured with quin 2. Cyclosporin A had no significant effect on basal quin 2 fluorescence. However, cyclosporin A increased the basal 45Ca2+ influx. This stimulation of 45Ca2+ influx was not blocked by nifedipine (10(-6) M). Cyclosporin A also augmented the angiotensin II-stimulated influx and efflux of 45Ca2+. These results demonstrate that cyclosporin A increases the permeability of the plasma membrane for Ca2+ and also augments the angiotensin II-induced increases in cytosolic free calcium.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3435490      PMCID: PMC1148632          DOI: 10.1042/bj2480883

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  31 in total

Review 1.  Cyclosporin A: a selective anti-T cell agent.

Authors:  B D Kahan
Journal:  Clin Haematol       Date:  1982-10

2.  Co-existence of vimentin and desmin type intermediate filaments in a subpopulation of adult rat vascular smooth muscle cells growing in primary culture.

Authors:  P Travo; K Weber; M Osborn
Journal:  Exp Cell Res       Date:  1982-05       Impact factor: 3.905

3.  Assembly-disassembly purification and characterization of microtubule protein without glycerol.

Authors:  D B Murphy
Journal:  Methods Cell Biol       Date:  1982       Impact factor: 1.441

4.  Targeted blood levels of cyclosporin for cardiac transplantation.

Authors:  B P Griffith; R L Hardesty; A Trento; A Lee; H T Bahnson
Journal:  J Thorac Cardiovasc Surg       Date:  1984-12       Impact factor: 5.209

5.  Calcium homeostasis in intact lymphocytes: cytoplasmic free calcium monitored with a new, intracellularly trapped fluorescent indicator.

Authors:  R Y Tsien; T Pozzan; T J Rink
Journal:  J Cell Biol       Date:  1982-08       Impact factor: 10.539

6.  Cyclophilin: a specific cytosolic binding protein for cyclosporin A.

Authors:  R E Handschumacher; M W Harding; J Rice; R J Drugge; D W Speicher
Journal:  Science       Date:  1984-11-02       Impact factor: 47.728

7.  Analysis of cloned T cell function. II. Differential blockade of various cloned T cell functions by cyclosporine.

Authors:  C G Orosz; D C Roopenian; M B Widmer; F H Bach
Journal:  Transplantation       Date:  1983-12       Impact factor: 4.939

8.  Role of phospholipase C and protein kinase C in vasoconstrictor-induced prostaglandin synthesis in cultured rat renal mesangial cells.

Authors:  J Pfeilschifter; A Kurtz; C Bauer
Journal:  Biochem J       Date:  1986-02-15       Impact factor: 3.857

9.  The smooth muscle cell. II. Growth of smooth muscle in culture and formation of elastic fibers.

Authors:  R Ross
Journal:  J Cell Biol       Date:  1971-07       Impact factor: 10.539

10.  Monoclonal antibodies to desmin, the muscle-specific intermediate filament protein.

Authors:  E Debus; K Weber; M Osborn
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

View more
  17 in total

1.  Potentiation of vascular smooth muscle cell activity by cyclosporin A.

Authors:  R Locher; R Huss; W Vetter
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

2.  Coronary vasomotor responses in cyclosporine-treated piglets.

Authors:  G Berkenboom; D Brékine; P Unger; B Gulbis; J Fontaine
Journal:  Cardiovasc Drugs Ther       Date:  1996-03       Impact factor: 3.727

3.  Cyclosporin A stimulates apical Na+/H+ exchange in LLC-PK1/PKE20 proximal tubular cells.

Authors:  Thomas Epting; Kathrin Hartmann; Anna Sandqvist; Roland Nitschke; Nader Gordjani
Journal:  Pediatr Nephrol       Date:  2006-05-11       Impact factor: 3.714

Review 4.  Transmembrane signaling in kidney health and disease.

Authors:  N Hack; A Schultz; P Clayman; H Goldberg; K L Skorecki
Journal:  Pediatr Nephrol       Date:  1995-08       Impact factor: 3.714

Review 5.  The pathophysiology of Sandimmune (cyclosporine) in man and animals.

Authors:  J Mason
Journal:  Pediatr Nephrol       Date:  1990-09       Impact factor: 3.714

6.  Down-regulation of protein kinase C potentiates angiotensin II-stimulated polyphosphoinositide hydrolysis in vascular smooth-muscle cells.

Authors:  J Pfeilschifter; M Ochsner; S Whitebread; M De Gasparo
Journal:  Biochem J       Date:  1989-08-15       Impact factor: 3.857

7.  Cyclosporin therapy in vivo attenuates the response to vasodilators in the isolated perfused kidney of the rabbit.

Authors:  H S Cairns; L D Fairbanks; J Westwick; G H Neild
Journal:  Br J Pharmacol       Date:  1989-10       Impact factor: 8.739

Review 8.  Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders.

Authors:  Diana Faulds; Karen L Goa; Paul Benfield
Journal:  Drugs       Date:  1993-06       Impact factor: 9.546

9.  Cellular signaling by cyclosporine A in contractile cells: interactions with atrial natriuretic peptide.

Authors:  H Meyer-Lehnert; D Bokemeyer; U Friedrichs; S Drechsler; H J Kramer
Journal:  Clin Investig       Date:  1993-02

10.  Effects of cyclosporine A on chick osteoclasts in vitro.

Authors:  M H Chowdhury; V Shen; D W Dempster
Journal:  Calcif Tissue Int       Date:  1991-10       Impact factor: 4.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.